<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>GIDS Research Radar · Macao</title>
  <link>https://globalinfectiousdisease.com/research/</link>
  <description>Published infectious-disease literature filtered to Macao.</description>
  <language>en</language>
  <atom:link href="https://globalinfectiousdisease.com/research/rss/countries/mo.xml" rel="self" type="application/rss+xml" />
  <lastBuildDate>Sat, 07 Nov 2026 03:45:11 GMT</lastBuildDate>
  <item>
    <title>Pragmatic weight estimation for dosing of a new paediatric treatment for schistosomiasis prevention and control in preschool-aged children: a feasibility study in Uganda and Côte d’Ivoire</title>
    <link>https://papers.globalinfectiousdisease.com/research/articles/10-1186-s40249-026-01507-9-be5ded26/</link>
    <guid isPermaLink="true">https://papers.globalinfectiousdisease.com/research/articles/10-1186-s40249-026-01507-9-be5ded26/</guid>
    <pubDate>Mon, 12 Oct 2026 00:00:00 GMT</pubDate>
    <description>Reliable weight estimation without scales may support dosing of paediatric praziquantel in community programmes and routine child health services.</description>
    <category>Schistosomiasis</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Development and evaluation of a multiplex PCR for simultaneous detection of Mycobacterium tuberculosis complex, Mycobacterium avium complex, and Burkholderia pseudomallei in clinical specimens</title>
    <link>https://papers.globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0014730-2fa88649/</link>
    <guid isPermaLink="true">https://papers.globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0014730-2fa88649/</guid>
    <pubDate>Thu, 24 Sep 2026 00:00:00 GMT</pubDate>
    <description>In co-endemic areas, the tool may support faster, differentiated detection and thus better case finding and management for the three infections.</description>
    <category>Tuberculosis</category>
    <category>Melioidosis</category>
    <category>Diagnostics</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>National and subnational burden of HIV-negative MDR-TB in China, 1990–2023: Spatio-temporal heterogeneity, long-term trends, and projections</title>
    <link>https://papers.globalinfectiousdisease.com/research/articles/10-1016-j-jinf-2026-106816-5a1d1c81/</link>
    <guid isPermaLink="true">https://papers.globalinfectiousdisease.com/research/articles/10-1016-j-jinf-2026-106816-5a1d1c81/</guid>
    <pubDate>Sat, 01 Aug 2026 00:00:00 GMT</pubDate>
    <description>Persistent challenges from rising prevalence and geographic unevenness in China point to needs for sustained policy, diagnostic, and community approaches.</description>
    <category>Tuberculosis</category>
    <category>Multidrug-resistant tuberculosis</category>
    <category>AIDS</category>
    <category>Health policy</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Analysis of imported Chikungunya cases in China from 2006 to 2026.</title>
    <link>https://papers.globalinfectiousdisease.com/research/articles/10-3389-fmicb-2026-1856429-54c7476e/</link>
    <guid isPermaLink="true">https://papers.globalinfectiousdisease.com/research/articles/10-3389-fmicb-2026-1856429-54c7476e/</guid>
    <pubDate>Fri, 29 May 2026 00:00:00 GMT</pubDate>
    <description>The study identifies imported chikungunya among returning travelers as relevant to possible reintroduction and local transmission in China. It emphasizes prevention, control, travel medicine, and vaccine approval as public health priorities.</description>
    <category>Chikungunya</category>
    <category>Travel medicine</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Vaccination</category>
    <category>Genomic epidemiology</category>
    <category>Genomic study</category>
  </item>
  <item>
    <title>National and subnational burden of XDR-TB in China, 1990–2023: Long-term trends, regional disparities, and projections, 2024–2050</title>
    <link>https://papers.globalinfectiousdisease.com/research/articles/10-1016-j-jinf-2026-106728-db5b382e/</link>
    <guid isPermaLink="true">https://papers.globalinfectiousdisease.com/research/articles/10-1016-j-jinf-2026-106728-db5b382e/</guid>
    <pubDate>Fri, 01 May 2026 00:00:00 GMT</pubDate>
    <description>Findings highlight geographic disparities and age-related patterns in XDR-TB burden across China and are positioned by the authors as a basis for precision control strategies and targeted interventions in high-risk regions, particularly Xinjiang and Tibet, with attention to elderly populations.</description>
    <category>Tuberculosis</category>
    <category>Antimicrobial resistance</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Unmasking Mycobacterium avium: two case reports of cutaneous lesions in HIV patients after initiation of an integrase inhibitor-based regimen</title>
    <link>https://papers.globalinfectiousdisease.com/research/articles/10-1186-s12879-026-12588-0-39b52e1c/</link>
    <guid isPermaLink="true">https://papers.globalinfectiousdisease.com/research/articles/10-1186-s12879-026-12588-0-39b52e1c/</guid>
    <pubDate>Wed, 21 Jan 2026 00:00:00 GMT</pubDate>
    <description>Clinicians should suspect non-tuberculous mycobacterial disease in advanced HIV patients with new inflammatory signs after treatment start, especially where diagnostic delay is frequent.</description>
    <category>AIDS</category>
    <category>Tuberculosis</category>
    <category>HIV infection</category>
    <category>Diagnostics</category>
    <category>Treatment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Explosive chikungunya virus outbreak in China</title>
    <link>https://papers.globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2025-108089-03cdb07e/</link>
    <guid isPermaLink="true">https://papers.globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2025-108089-03cdb07e/</guid>
    <pubDate>Mon, 01 Dec 2025 00:00:00 GMT</pubDate>
    <description>The unprecedented scale shows how ecological and mobility factors can turn local introductions into major epidemics, highlighting needs for surveillance, genomics, data sharing, and vaccine readiness.</description>
    <category>Chikungunya</category>
    <category>Outbreak investigation</category>
    <category>Travel medicine</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Vaccination</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Development and evaluation of recombinant E2 protein based IgM capture enzyme-linked immunosorbent assay (ELISA) and double antigen sandwich ELISA for detection of antibodies to Chikungunya virus</title>
    <link>https://papers.globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0010829-c9cafb69/</link>
    <guid isPermaLink="true">https://papers.globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0010829-c9cafb69/</guid>
    <pubDate>Thu, 08 Dec 2022 00:00:00 GMT</pubDate>
    <description>The assays may support lab diagnosis and serological investigation to evaluate chikungunya transmission risk per the authors&apos; stated use.</description>
    <category>Chikungunya</category>
    <category>Diagnostics</category>
    <category>Transmission dynamics</category>
    <category>Travel medicine</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors</title>
    <link>https://papers.globalinfectiousdisease.com/research/articles/10-1038-s41467-021-22362-2-89d72344/</link>
    <guid isPermaLink="true">https://papers.globalinfectiousdisease.com/research/articles/10-1038-s41467-021-22362-2-89d72344/</guid>
    <pubDate>Thu, 01 Apr 2021 00:00:00 GMT</pubDate>
    <description>The three compounds may serve as chemical starting points for developing SARS-CoV-2 3CL protease inhibitors, but the supplied abstract does not establish antiviral efficacy or clinical utility.</description>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>Outbreak investigation</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Update: Increase in Human Infections with Novel Asian Lineage Avian Influenza A(H7N9) Viruses During the Fifth Epidemic — China, October 1, 2016–August 7, 2017</title>
    <link>https://papers.globalinfectiousdisease.com/research/articles/10-15585-mmwr-mm6635a2-b7cfd6ed/</link>
    <guid isPermaLink="true">https://papers.globalinfectiousdisease.com/research/articles/10-15585-mmwr-mm6635a2-b7cfd6ed/</guid>
    <pubDate>Fri, 08 Sep 2017 00:00:00 GMT</pubDate>
    <description>Asian H7N9 carries the highest pandemic potential among assessed influenza viruses per the IRAT. Agencies are enhancing surveillance, lab detection, and candidate vaccine virus development to support preparedness.</description>
    <category>H7N9</category>
    <category>Influenza</category>
    <category>H5N1</category>
    <category>Surveillance</category>
    <category>Vaccination</category>
    <category>Treatment</category>
    <category>Climate and environment</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Increase in Human Infections with Avian Influenza A(H7N9) Virus During the Fifth Epidemic — China, October 2016–February 2017</title>
    <link>https://papers.globalinfectiousdisease.com/research/articles/10-15585-mmwr-mm6609e2-b45115ca/</link>
    <guid isPermaLink="true">https://papers.globalinfectiousdisease.com/research/articles/10-15585-mmwr-mm6609e2-b45115ca/</guid>
    <pubDate>Fri, 10 Mar 2017 00:00:00 GMT</pubDate>
    <description>The marked increase in human A(H7N9) cases during the fifth epidemic represents a significant public health concern given the high severity of illness (88% pneumonia, 68% ICU admission, 41% mortality in earlier epidemics) and continued risk from poultry exposure.</description>
    <category>Influenza</category>
    <category>H7N9</category>
    <category>H5N1</category>
    <category>Travel medicine</category>
    <category>Transmission dynamics</category>
    <category>Outbreak investigation</category>
    <category>Vaccination</category>
    <category>Journal article</category>
  </item>
  <item>
    <title>Mycobacteria causing human cervical lymphadenitis in pastoral communities in the Karamoja region of Uganda</title>
    <link>https://papers.globalinfectiousdisease.com/research/articles/10-1017-s0950268807009004-9be591f6/</link>
    <guid isPermaLink="true">https://papers.globalinfectiousdisease.com/research/articles/10-1017-s0950268807009004-9be591f6/</guid>
    <pubDate>Fri, 29 Jun 2007 00:00:00 GMT</pubDate>
    <description>The findings document human infection with zoonotic mycobacteria in communities where raw milk and meat consumption is routine, and highlight occupational risk from environmental mycobacteria in transhumant ecosystems lacking safe drinking water.</description>
    <category>Tuberculosis</category>
    <category>One Health</category>
    <category>Treatment</category>
    <category>Climate and environment</category>
    <category>Journal article</category>
  </item>
</channel>
</rss>
